1 / 6

Questions

Questions. 1) You should consider the diagnosis of COPD in the following patient types: 60 year non-smoker with chronic cough and sputum production 50 year old with a 15 pack-year tobacco history with no chronic respiratory symptoms 45 yo smoker with 10 pack-year history with dyspnea

xavier-booker
Download Presentation

Questions

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Questions 1) You should consider the diagnosis of COPD in the following patient types: 60 year non-smoker with chronic cough and sputum production 50 year old with a 15 pack-year tobacco history with no chronic respiratory symptoms 45 yo smoker with 10 pack-year history with dyspnea All of the above Only a and c Answer is (D)

  2. Question 2 2) Staging of COPD severity is based primarily upon: • Frequency of respiratory symptoms • Severity of respiratory symptoms • FEV1/FVC • FEV1 Answer (D)

  3. Question 3 3) Which of the following is false regarding bronchodilators in COPD? • Short-acting inhaled agents such as albuterol and/or ipratropium are indicated in all stages of severity of COPD • Tiotropium is the most potent long-acting bronchodilator in COPD • It is recomended to continue usual doses of ipratropium in COPD patients being prescribed tiotropium D. Theophylline is generally reserved for patients unbale to tolerate inhaled long-acting agents or as an add-on to inhlaed long-acting bronchodilators Answer (C)

  4. Question 4 4) Which of the following is true regarding inhaled corticostreoids in COPD? • Normally modifies progression of disease • Decreases frequency of flares in COPD patients with severe to very severe disease • Recommended for mild and moderate disease- similar to asthma • Turbuhaler(R) inhaler provides excellent lung deposition in most COPD patients Answer: (B)

  5. Question 5 5) Which of the following is false regarding glucocorticoid-induced osteoporosis (GIO)? • Therapy for GIO only indicated in COPD patients on at least 7.5 mg/day chronically • Calcium citrate + Vit D and a bisphosphonate is a recommended regimen in a patient receiving at least 4 courses of prednisone per year • Calcium + Vit D supplementation is recommended in a COPD patient receiving Advair 500 • All of the above are true Answer: (D)

  6. Question 6 6) Antibiotics are indicated in a COPD patient who: • Has increased volume of sputum only with no other signs of infection • Has increased volume and mucopurulence of sputum • Has dyspnea, increased sputum, and sputum is more mucopurulent • Only b and c • Only a and b Answer: (D)

More Related